000 04296naa a22005297i 4500
001 UMUN-OA-20261005-MLS-030
003 local
005 20261005174903.0
006 m o d
007 cr||||||||||||
008 261005s2022 xx o u000 0 eng d
024 7 _a10.3390/jcm11102859
_2doi
035 _a(local)EuropePMC:PMC9144124
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aTheresa Ackfeld
_eauthor.
245 1 0 _aBlood Transfusion Reactions-A Comprehensive Review of the Literature including a Swiss Perspective. /
_cTheresa Ackfeld; Thomas Schmutz; Youcef Guechi [and others].
264 1 _a[Place of publication not identified] :
_bMultidisciplinary Digital Publishing Institute (MDPI),
_c2022.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aBlood transfusions have been the cornerstone of life support since the introduction of the ABO classification in the 20th century. The physiologic goal is to restore adequate tissue oxygenation when the demand exceeds the offer. Although it can be a life-saving therapy, blood transfusions can lead to serious adverse effects, and it is essential that physicians remain up to date with the current literature and are aware of the pathophysiology, initial management and risks of each type of transfusion reaction. We aim to provide a structured overview of the pathophysiology, clinical presentation, diagnostic approach and management of acute transfusion reactions based on the literature available in 2022. The numbers of blood transfusions, transfusion reactions and the reporting rate of transfusion reactions differ between countries in Europe. The most frequent transfusion reactions in 2020 were alloimmunizations, febrile non-hemolytic transfusion reactions and allergic transfusion reactions. Transfusion-related acute lung injury, transfusion-associated circulatory overload and septic transfusion reactions were less frequent. Furthermore, the COVID-19 pandemic has challenged the healthcare system with decreasing blood donations and blood supplies, as well as rising concerns within the medical community but also in patients about blood safety and transfusion reactions in COVID-19 patients. The best way to prevent transfusion reactions is to avoid unnecessary blood transfusions and maintain a transfusion-restrictive strategy. Any symptom occurring within 24 h of a blood transfusion should be considered a transfusion reaction and referred to the hemovigilance reporting system. The initial management of blood transfusion reactions requires early identification, immediate interruption of the transfusion, early consultation of the hematologic and ICU departments and fluid resuscitation.
540 _aCreative Commons Attribution. See the linked licence for the applicable terms.
_uhttps://creativecommons.org/licenses/by/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Medical Laboratory Science.
650 4 _aPulmonary Complications
650 4 _aErythrocyte Transfusion
650 4 _aAdverse Transfusion Reactions
650 4 _aBlood Cell Transfusion
650 4 _aAnemia Treatment
653 _aB. Sc. Medical Laboratory Science
653 _aUMUN open access collection
653 _ablood transfusion
655 4 _aReview articles.
700 0 _aThomas Schmutz
_eauthor.
700 0 _aYoucef Guechi
_eauthor.
700 0 _aChristophe Le Terrier
_eauthor.
773 0 _tJournal of clinical medicine
_gVol. 11, no. 10, (2022), pages/article 2859
_x2077-0383
856 4 0 _uhttps://europepmc.org/articles/PMC9144124
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC9144124
_qlocal
942 _n0
999 _c1172
_d1172